Genocea Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GNCAQ and buy or sell other stocks, ETFs, and their options commission-free!About GNCAQ
Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses.
CEOChip Clark, MBA
CEOChip Clark, MBA
Employees74
Employees74
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2006
Founded2006
Employees74
Employees74
GNCAQ Key Statistics
Market cap0.00
Market cap0.00
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume173.00
Average volume173.00
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume100.00
Volume100.00
52 Week high$0.0001
52 Week high$0.0001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
The current Genocea Biosciences(GNCAQ) stock price is $0.00, with a market capitalization of 0.
On 2026-04-13, Genocea Biosciences(GNCAQ) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 100, compared to an average daily volume of 173.
Over the past 52 weeks, Genocea Biosciences(GNCAQ) stock has traded between a high of $0.00 and a low of $0.00.
Over the past 52 weeks, Genocea Biosciences(GNCAQ) stock has traded between a high of $0.00 and a low of $0.00.
People also own
Based on the portfolios of people who own GNCAQ. This list is generated using Robinhood data, and it’s not a recommendation.